• Topics

  • Formats

Published 17 August 2026

Author(s): Digital Science

More isn’t necessarily better for R&D and Medical Affairs teams looking to augment the research data they already have. Life sciences organizations need access to data sets that are robust, standardized and structured. They also benefit from full-text research and patent documents – not just abstracts and summaries – and AI-driven technology layers to unlock insights across disparate data sets.

Read this white paper to learn:

  • Why a database that’s updated and trustworthy in addition to robust is a differentiator for life sciences research
  • How normalized and standardized data sets help organizations uncover connections in research, real-world attention, and patent information
  • How the in-depth evidence and technological knowledge from full-text searches supports business decision-making
  • Why organizations should seek data ready for application programming interfaces (APIs) and model context protocols (MCPs)
  • How MCPs from trusted technology partners can transform search from keywords to semantic search

Reading this content is completely free

Enjoy Unlimited Access and Unlock
Additional Features with a Free Account

Join Now

You are attempting to log out of MyMA

Do you really want to log out?